For the quarter ended December 2024, Amicus Therapeutics (FOLD) reported revenue of $149.71 million, up 30.1% over the same period last year. EPS came in at $0.09, compared to -$0.11 in the year-ago quarter.The reported revenue represents a surprise of -0.13% over the Zacks Consensus Estimate of $149.89 million. With the consensus EPS estimate being $0.10, the EPS surprise was -10.00%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to ...